Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adderall-XR vs Concerta for Neurocognitive Sequelae in Pediatric Cancer
NCT00069927Phase 2Terminated
- Sponsor
- University of South Florida
- Start
- Aug 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of adderall xr, methylphenidate in neurocognitive disorders (NCDs), major depressive disorder (MDD), sponsored by University of South Florida. Started Aug 2003; status: terminated.
02
Drugs
adderall xrmethylphenidate
03
Conditions
neurocognitive disorders (NCDs)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00069927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069927.